IRIS - Res&Arch Institutional Research Information System - Research & Archive

IORIO, Anna Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.678
AS - Asia 1.953
EU - Europa 1.854
SA - Sud America 343
AF - Africa 36
OC - Oceania 2
Totale 6.866
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.603
SG - Singapore 838
IE - Irlanda 379
UA - Ucraina 372
HK - Hong Kong 280
BR - Brasile 279
VN - Vietnam 252
CN - Cina 246
RU - Federazione Russa 238
DE - Germania 170
IT - Italia 152
FI - Finlandia 134
FR - Francia 104
SE - Svezia 104
GB - Regno Unito 78
KR - Corea 74
TR - Turchia 57
IN - India 46
CA - Canada 44
BD - Bangladesh 29
BE - Belgio 26
AR - Argentina 25
MX - Messico 23
PK - Pakistan 16
NL - Olanda 15
PL - Polonia 14
ES - Italia 13
IQ - Iraq 12
SA - Arabia Saudita 12
CH - Svizzera 11
ID - Indonesia 11
LB - Libano 11
UZ - Uzbekistan 10
AT - Austria 9
CZ - Repubblica Ceca 9
JP - Giappone 9
CO - Colombia 8
EC - Ecuador 8
CL - Cile 7
GR - Grecia 7
MA - Marocco 7
MY - Malesia 7
ZA - Sudafrica 7
JO - Giordania 6
TN - Tunisia 6
VE - Venezuela 6
AZ - Azerbaigian 5
IL - Israele 5
LT - Lituania 5
PY - Paraguay 5
RO - Romania 4
BG - Bulgaria 3
KE - Kenya 3
NP - Nepal 3
OM - Oman 3
PH - Filippine 3
BY - Bielorussia 2
CG - Congo 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
KH - Cambogia 2
PE - Perù 2
TH - Thailandia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AM - Armenia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GD - Grenada 1
GH - Ghana 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PW - Palau 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
TZ - Tanzania 1
YE - Yemen 1
Totale 6.866
Salva come PNG Salva come JPEG
Città #
Singapore 611
Chandler 383
Dublin 379
Hong Kong 280
San Jose 263
Jacksonville 216
San Mateo 181
Dong Ket 157
Ashburn 137
Boardman 98
Santa Clara 94
Ann Arbor 93
Moscow 85
Medford 77
Princeton 77
Munich 72
Lauterbourg 71
Beijing 67
Seoul 58
Wilmington 55
Andover 48
Ho Chi Minh City 41
Helsinki 39
Izmir 38
Los Angeles 32
Perugia 30
São Paulo 30
New York 25
Orem 25
Des Moines 24
Brussels 23
Saint Petersburg 21
Piscataway 19
Turku 19
Hanoi 18
Ottawa 18
Altamura 17
Genoa 17
Brooklyn 16
The Dalles 16
Norwalk 15
Woodbridge 15
Dongjak-gu 14
Frankfurt am Main 14
Houston 13
London 13
Chennai 12
Boston 11
Florence 11
Shanghai 11
Columbus 10
Lawrence 10
Redwood City 10
Stockholm 10
Manchester 9
Mexico City 9
Tokyo 9
Warsaw 9
Amsterdam 8
Montreal 8
Nuremberg 8
Ankara 7
Dallas 7
Rio de Janeiro 7
Amman 6
Belo Horizonte 6
Chicago 6
Da Nang 6
Denver 6
Guarulhos 6
Redmond 6
Toronto 6
Atlanta 5
Baku 5
Dhaka 5
Düsseldorf 5
Falls Church 5
Fortaleza 5
Johannesburg 5
Lahore 5
Milan 5
Olomouc 5
Poplar 5
Porto Alegre 5
Portsmouth 5
Rome 5
San Francisco 5
Seattle 5
Sorocaba 5
Tianjin 5
Auburn Hills 4
Baghdad 4
Brasília 4
Buffalo 4
Calgary 4
Campinas 4
Caxias do Sul 4
Den Haag 4
Itaquaquecetuba 4
Jeddah 4
Totale 4.398
Salva come PNG Salva come JPEG
Nome #
Antibody response and protection after intradermal and intramuscular 2011/2012 trivalent influenza vaccination in elderly volunteers 144
"Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age" 4th National Congress of the Italian Society of Virology (SIV) 140
" MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and elderly volunteers (winter season 2003/2004)" 140
An influenza A/H3N2 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home 132
Antibody Responses after Influenza Vaccination in Elderly People: Useful Information from a 27-Year Study (from 1988–1989 to 2014–2015) 125
Effect of age on serum heterologous antibody response elicited by inactivated influenza virus vaccine” 7th National Congress of the Italian Society of Virology 123
Influenza vaccination in patients on long-term anticoagulant therapy 123
[Colony inhibition test (C.I.T.) and the cytotoxic adherence test (C.A.T.): some comparative data]. 121
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 119
An influenza A/H3 outbreak during the 2004/2005 winter in elderlyvaccinated people living in a nursing home 118
Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59 adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy. 117
Annually repeated influenza vaccination and humoral response in elderly volunteers. 115
An influenza B outbreak in elderly vaccinated people in the winter season 2007/2008” The Third European Influenza Conference 114
Immunogenicità ed efficacia protettiva del vaccino influenzale per l’inverno 2007/08 in soggetti anziani residenti in casa di riposo” 36° Congresso Nazionale della Società Italiana di Microbiologia 112
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age. 111
An influenza A/H3 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home. 110
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. 110
An observational retrospective study provide information on hospitalization and severe outcomes of the 2009 A(H1N1) infection in Italy. 110
Antibody response elicited by 2012/2013 “implemented influenza vaccines”, FLUAD® (Novartis Vaccines & Diagnostics) and INTANZA® 15Mcg (Sanofi Pasteur MSD), in chronically ill institutionalized elderly volunteers 108
I benefici della vaccinazione influenzale Analisi e prospettive nella popolazione non anziana a rischio 107
Antibody response against unchanged influenza vaccine components in elderly people vaccinated in consecutive years 107
Influenza vaccine immunogenicity and efficacy in istitutionalized elderly volunteers (winter season 2002/03). 105
Clinical characteristics of influenza A/H1N1, A/H3N2 and B infections in children during three consecutive winter seasons (2012-13, 2013-14 and 2014-15) 104
[Natural resistance and induced resistance to ATPC + tumor in mice]. 103
Differente risposta anticorpale al vaccine anti-influenzale per l’inverno 2008/2009 in soggetti anziani residenti in due differenti case di riposo. 103
Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages 101
Immunobiological aspects of the nude mouse model relative to human cancer chemosensitivity tests. 101
Induzione di risposta immunitaria e di protezione da parte dei vaccini antinfluenzali in soggetti anziani. 100
Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. 99
Influenza vaccine induced antibody response against B influenza viruses included in the vaccine or naturally circulating during the winter season 2010/2011 98
[The serum protein picture in mice with ATPC ascites tumors studied by means of disk electrophoresis]. 97
Induction of cross-reactive antibodies to 2009 pandemic H1N1 influenza virus (pH1N1) after seasonal vaccination (winters 2003/04 and 2007/08). 96
Comparative study on immunogenicity among split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 96
Immunogenicity of conventional trivalent inactivated influenza vaccines in pre-vaccination unprotected elderly volunteers in five winters seasons. 92
Comparative study of immunogenicity of split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 92
Proceedings of the X National Biotechnology Congress. 90
[Selective inhibition of the response to the allograft of a virus in mice] 89
The effect of influenza vaccination in patients on long-term oral anticoagulant therapy 88
Immunization with adjuvanted and non-adjuvanted influenza vaccines of HIV-1 positive patients treated with highly active antiretroviral therapy (HAART) 87
Pro-inflammatory cytokines/ chemokines production after infection of A549 Human epithelial cell line with different strains of human influenza viruses 87
Pandemic Influenza A/H1N1pdm in Italy: Age, Risk and Population Susceptibility 85
Hospitalization associated with 2009 pandemic influenza A(H1N1) infection in Umbria, a region of central Italy, July – December 2009. 84
MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and enderly volunteers (winter season 2003/04). 84
Influenza vaccine induction of cross–reactive antibodies against different B/Yamagata and B/Victoria-like influenza viruses. , 83
null 83
Cross-reactive antibodies to viruses of both B/Victoria and B/Yamagata lineages as induced by influenza vaccination in middle-aged and elderly volunteers 82
The intersubunit region of influenza virus haemagglutinin as a peptide vaccine candidate. 81
Twenty-seven years experience with immunogenicity of inactivated influenza vaccines in the elderly 81
Induction of Cross-Reactive Antibodies to 2009 Pandemic H1N1 Influenza Virus (pH1N1) After Seasonal Vaccination (Winters 2003/04 and 2007/08) 80
Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study. 80
Declined antibody response following influenza vaccination in elderly as compared with middle-aged volunteers: effects of aging and/or original antigenic sin? 79
Immunogenicity of the MF-59-adjuvanted vaccine in volunteers of different group of age. 79
Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. 79
Influenza B virus circulation in elderly vaccinated people living in a nursing home in the winter season 2007/2008” 8th National Congress of the Italian Society of Virology 77
Synthesis and immuno-characterization of HSV-1 peptides for a potential vaccine 77
VALUTAZIONE DELL’EFFICACIA PROTETTIVA E DELLA CAPACITA’ DI INDURRE ANTICORPI CROSS-REATTIVI NEI CONFRONTI DI VIRUS INFLUENZALI DI TIPO B APPARTENENTI AI LINEAGGI YAMAGATA E VICTORIA DA PARTE DI DUE VACCINI INFLUENZALI TRIVALENTI (FLUAD® E INTANZA®) IN ANZIANI ISTITUZIONALIZZATI 76
Partial Protection Induced by 2011–2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People 76
Immunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users. 75
Induzione di anticorpi omologhi e cross-reattivi nei confronti di virus influenzali di tipo B da parte del vaccino influenzale nell'inverno 2003/2004 73
Seroprevalence against pandemic influenza A(H1N1) 2009 after the first season of circulation in Italy 73
Serologically diagnosed influenza virus A/California/7/04 (H3N2)infection in people immunised with A/Fujan/411/2002(H3N2)antigen during the 2004/05 winter season 71
Sorveglianza delle paralisi flaccide acute nella regione Umbria 69
Factors influencing humoral immune response after influenza vaccination in elderly and very elderly subjects 68
Increased immunogenicity of an adjuvanted influenza vaccine compared with a conventional subunit vaccine in non-elderly adult HIV seropositive individuals, treated with HAART 67
Intradermal and intramuscular 2011-2012 influenza vaccination of elderly institutionalized volunteers: induction of antibody responses against vaccine and epidemic influenza virus strains 66
Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus 66
Sorveglianza molecolare delle gastroenteriti da rotavirus in Umbria 65
Radioresistant Inhibition of Tumors (RIT): Biological and Pharmacological Studies 64
ENDOGENOUS INTERLEUKYN-6 LEVELS AND ANTIBODY RESPONSE TO INACTIVATED INFLUENZA VACCINE IN PLURIVACCINATED ELDERLY VOLUNTEERS 63
Influenza A virus specific T cell immunity in humans during ageing 62
Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review 62
Soggetti ricoverati in ospedale in Umbria con diagnosi di laboratorio di infezione da virus influenzale pandemico A/H1N1 nel periodo Luglio 2009 - Marzo 2010 61
The new pandemic A/H1N1 influenza virus (pH1N1): celluler and humoral cross-reactive immune responses induced in healthy adults following 2007/2008 influenza vaccination. 60
Seroprevalence to the 2009 pandemic influenza a(H1N1) virus in the italian population after the 2009 pandemic (September/November 2010) 60
Laboratory confirmed pandemic H1N1 influenza virus infections in hospitalization in Umbria, a region of central Italy (May-November 2009). 58
Serological evidence of partial protection against infection with A/H3N2 circulating drifted strains after immunization with enhanced 2011/2012 trivalent influenza vaccines 56
Influenza vaccination in patients on long-term anticoagulant therapy 52
A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60–85 years old) and very elderly (>85 years old) institutionalized subjects 16
Totale 7.007
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.655
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021162 0 0 0 0 0 0 0 0 0 0 0 162
2021/2022581 11 109 4 14 26 6 6 211 5 23 76 90
2022/20231.113 89 109 20 93 88 119 0 63 484 3 35 10
2023/2024483 32 45 30 9 3 1 125 28 71 4 86 49
2024/20251.144 15 114 31 59 181 38 46 36 223 78 196 127
2025/20262.226 167 149 84 281 282 218 380 107 329 166 56 7
Totale 7.007